PedAM
Pediatric Disease Annotations & Medicines
| Disease | arteriosclerosis |
| Phenotype | C1561644|chronic kidney disease (ckd) |
| Sentences | 17 |
| PubMedID- 26042415 | Background: chronic kidney disease (ckd) is associated with accelerated atherosclerosis and an increased risk of adverse cardiovascular disease (cvd) outcomes. |
| PubMedID- 20602330 | Background and aims: this study aimed to test the hypothesis that visfatin is associated with atherosclerosis in patients with chronic kidney disease (ckd). |
| PubMedID- 22781707 | Aims: indoxyl sulfate, a uremic toxin, is considered a risk factor for arteriosclerosis in patients with chronic kidney disease (ckd). |
| PubMedID- 22937042 | Impaired hemostasis coexists with accelerated atherosclerosis in patients with chronic kidney disease (ckd). |
| PubMedID- 20592243 | chronic kidney disease (ckd) is associated with accelerated atherosclerosis and cardiovascular disease, which is largely mediated by oxidative stress. |
| PubMedID- 20940700 | The development of atherosclerosis in patients with chronic kidney disease (ckd) is severely accelerated leading to life-threatening cardiovascular (cv) events and its pathogenesis is different from that in the general population. |
| PubMedID- 20308998 | chronic kidney disease (ckd) is associated with development of atherosclerosis and premature death from cardiovascular disease. |
| PubMedID- 20190248 | Background: chronic kidney disease (ckd) is associated with accelerated atherosclerosis and an inadequate inflammatory response which may account for the high morbidity and mortality observed in this population. |
| PubMedID- 21071957 | Changes mediated by oxidative stress are thought to be involved with atherosclerosis in patients with chronic kidney disease (ckd). |
| PubMedID- 24085020 | Background and purpose: we aimed to clarify the association of chronic kidney disease (ckd) with carotid atherosclerosis and the impact of ckd on carotid atherosclerosis according to blood pressure categories in an urban general population. |
| PubMedID- 20083473 | Background: endothelial dysfunction contributes to accelerated atherosclerosis in chronic kidney disease (ckd). |
| PubMedID- 21226275 | atherosclerosis is common in patients with chronic kidney disease (ckd), and cardiovascular disease (cvd) represents a major cause of death in these patients, especially, in patients with end-stage renal disease(esrd). |
| PubMedID- 26287243 | One of the possible causes of enhanced atherosclerosis in patients with chronic kidney disease (ckd) is the accumulation of uremic toxins. |
| PubMedID- 25728732 | Background: chronic kidney disease (ckd) is associated with accelerated atherosclerosis and adverse cardiovascular outcomes, but mechanisms are unclear. |
| PubMedID- 21976741 | Background: the pathophysiology of aggravated atherosclerosis in chronic kidney disease (ckd) is still incompletely understood. |
| PubMedID- 21823040 | Adiponectin (adpn) counteracts the inflammatory response of the endothelium, which plays an important role in the development of atherosclerosis in patients with chronic kidney disease (ckd). |
| PubMedID- 26536302 | Objective: this 8-year follow-up cohort study evaluated and compared the degree of coronary atherosclerosis in chronic kidney disease (ckd) according to the kidney disease: improving global outcomes (kdigo) classification using multivessel angioscopy and investigated the impact of the vulnerability of coronary arteries on the relationship between the classification and risk of acute coronary syndromes (acs). |
Page: 1